Multiple mechanisms are involved in differentiation induced by arsenic trioxide in acute promyelocytic leukemia.

被引：0
|
作者：
Shen, YL [1 ]
Zhu, Q [1 ]
Cai, X [1 ]
Yu, Y [1 ]
Jia, PM [1 ]
Chen, GQ [1 ]
Wang, ZY [1 ]
Chen, SJ [1 ]
Chen, Z [1 ]
机构：
[1] Shanghai Med Univ 2, Rui Jin Hosp, Shanghai Inst Hematol, Shanghai, Peoples R China
来源：
BLOOD | 2000年 / 96卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1338
引用
收藏
页码：310A / 310A
页数：1
相关论文
共 50 条
  • [1] Retinoic acid and arsenic trioxide for acute promyelocytic leukemia.
    Hunt, Daniel P.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2014, 370 (19): : 1866 - 1866
  • [2] Pharmacokinetics of arsenic trioxide in patients with acute promyelocytic leukemia.
    Nagy, AJ
    Wang, ZG
    Maslak, P
    Chanel, S
    Ho, R
    Spriggs, D
    Tong, W
    Ellison, R
    Pandolfi, PP
    Warrell, RP
    Soignet, SL
    [J]. JOURNAL OF INVESTIGATIVE MEDICINE, 1999, 47 (02) : 100A - 100A
  • [3] Synergistic effect of gefitinib and arsenic trioxide in acute promyelocytic leukemia.
    Almeida, Luciana Yamamoto
    Araujo Silva, Cleide Lucia
    Weinhauser, Isabel
    Candido, Larissa Ananias
    Scheucher, Priscila Santos
    Oliveira Menezes Bonaldo, Camila Cristina
    Aparecida Santana, Barbara Amelia
    Gouvea Lima Yamada, Ana Silvia
    Rego, Eduardo Magalhaes
    [J]. CLINICAL CANCER RESEARCH, 2018, 24 (01) : 81 - 82
  • [4] Arsenic trioxide in the treatment of newly diagnosed acute promyelocytic leukemia.
    Mathews, V
    Chandy, M
    Srivastava, A
    Poonkuzhali, B
    Shaji, RV
    George, B
    [J]. BLOOD, 2001, 98 (11) : 216B - 216B
  • [5] Clinical observation on arsenic trioxide in the treatment of acute promyelocytic leukemia.
    Ma, J
    Liu, JW
    Jin, MH
    Xia, GQ
    [J]. EXPERIMENTAL HEMATOLOGY, 1997, 25 (08) : 484 - 484
  • [6] Clinical observation on arsenic trioxide in the treatment of relapsed acute promyelocytic leukemia.
    Ma, J
    Jin, MH
    Chen, LY
    Liang, H
    Zhang, Y
    [J]. BLOOD, 1998, 92 (10) : 404A - 404A
  • [7] Arsenic trioxide in the treatment of acute promyelocytic leukemia. A review of current evidence
    Sanz, Miguel A.
    Fenaux, Pierre
    Lo Coco, Francesco
    Amadori, Sergio
    Buchner, T.
    Burnett, Alan K.
    Cimino, Giuseppe
    Doehner, H.
    Dombret, Herve
    Lengfelder, E.
    Lowenberg, Bob
    Ludwig, H.
    Sanz, Miguel
    [J]. HAEMATOLOGICA, 2005, 90 (09) : 1231 - 1235
  • [8] Sensorimotor polyneuropathy following arsenic trioxide therapy for relapsed acute promyelocytic leukemia.
    Densmore, JJ
    Hess, CE
    Ross, M
    [J]. BLOOD, 1999, 94 (10) : 228B - 228B
  • [9] In vivo effects of arsenic trioxide in refractory acute myeloid leukemia other than acute promyelocytic leukemia.
    Geissler, K
    Berer, A
    Gisslinger, H
    Keil, F
    Valent, P
    Osterode, W
    Lechner, K
    [J]. BLOOD, 1999, 94 (10) : 229B - 229B
  • [10] Arsenic trioxide mechanisms of action - looking beyond acute promyelocytic leukemia
    Carney, Dennis A.
    [J]. LEUKEMIA & LYMPHOMA, 2008, 49 (10) : 1846 - 1851
12345